MOMA Therapeutics’ $150 Million Series B Financing

Goodwin Procter advised MOMA Therapeutics on the deal.MOMA Therapeutics announced its completion of a $150 million Series B Financing. MOMA Therapeutics is a biopharmaceutical company discovering…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now